secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioNexus Gene Lab Corp (BGLC)
CIK:        0001737523
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0001477932-25-004754
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioNexus Gene Lab appoints Chong Set Fui as CFO effective immediately
---------------------------------------------------------------------

- Appointed Chong Set Fui (Angeline) as CFO and Principal Financial Officer, effective June 17, 2025.
- Chong has 25+ years senior financial experience, most recently CFO of Avillion Berhad (2013-2024).
- Monthly salary RM15,000 (~$3,500 USD) plus medical, fuel allowance, and discretionary bonus.
- Appointment is for a fixed term from June 17, 2025 to June 16, 2027, renewable with one-month notice.
- Su-Leng Tan Lee ceased as acting CFO concurrently.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737523/000147793225004754/0001477932-25-004754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737523/000147793225004754/bglc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-25-004754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer